[ZLAB]
Mid
Row
2026-10-23 15:32:43
Zai Lab announces $250M private placement
Mid
2026-09-14 08:35:25
Zipalertinib plus chemo shows survival benefit in lung cancer trial
Mid
2026-08-07 05:40:44
Zai Lab anticipates Zoci approval in 2028 as it targets 3 registrational programs by year-end
Row
2026-08-06 19:47:53
Zai Lab reports Q2 results
Mid
2026-08-03 22:43:45
Zai Lab receives Orphan Drug status for ADC for neuroendocrine carcinomas
1 / 2